TearScience is looking forward to the 2016 meeting!
TearScience® is a medical device company that pioneers breakthrough technologies to significantly improve identification, diagnosis, and treatment of Meibomian Gland Dysfunction (MGD). MGD, the leading cause of dry eye, is chronic and progressive and affects approximately 300 million people worldwide. The TearScience® Solution for MGD is a comprehensive in-office diagnosis and treatment solution that includes the LipiView® Ocular Surface Interferometer, the Korb Meibomian Gland Evaluator™, and the LipiFlow® Thermal Pulsation System. It is FDA-cleared and has been clinically proven to improve outcomes in patients with MGD. For additional information on how TearScience® is improving gland function and alleviating symptoms for patients with MGD worldwide, please visit www.TearScience.com.